|
1
|
International Committee on Taxonomy of
Viruses (ICTV). http://ictvonline.org/taxonomyHistory.asp?taxnode_id=20114200&taxa_name=Newcastle%20disease%20virus.
2012
|
|
2
|
Choppin PW and Compans RW: Reproduction of
Paramyxoviruses. Comprehensive Virology. Fraenkel-Conrat H and
Wagner RR: 4. Plenum Press; New York: pp. 95–178. 1975, View Article : Google Scholar
|
|
3
|
Stone-Hulslander J and Morrison TG:
Detection of an interaction between the HN and F proteins in
Newcastle disease virus-infected cells. J Virol. 71:6287–6295.
1997.PubMed/NCBI
|
|
4
|
Steward M, Vipond IB, Millar NS and
Emmerson PT: RNA editing in Newcastle disease virus. J Gen Virol.
74:2539–2547. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alexander DJ: Newcastle disease. Br Poult
Sci. 42:5–22. 2001. View Article : Google Scholar
|
|
6
|
Kumar R, Tiwari AK, Chaturvedi U, et al:
Velogenic Newcastle disease virus as an oncolytic virotherapeutics:
in vitro characterization. Appl Biochem Biotechnol. 167:2005–2022.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sinkovics JG and Horvath JC: Newcastle
disease virus (NDV): brief history of its oncolytic strains. J Clin
Virol. 16:1–15. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lai MC and Ibrahim AL: Velogenic
viscerotropic Newcastle disease virus. Newcastle Disease in
Poultry: a new food pellet vaccine. Copland JW: (Vol monograph 5).
ACIAR; Canberra: pp. 33–34. 1987
|
|
9
|
Millar NS, Chambers P and Emmerson PT:
Nucleotide sequence analysis of the haemagglutinin-neuraminidase
gene of Newcastle disease virus. J Gen Virol. 67:1917–1927. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang Z, Panda A, Elankumaran S,
Govindarajan D, Rockemann DD and Samal SK: The
hemagglutinin-neuraminidase protein of Newcastle disease virus
determines tropism and virulence. J Virol. 78:4176–4184. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Choppin PW and Scheid A: The role of viral
glycoproteins in adsorption, penetration, and pathogenicity of
viruses. Rev Infect Dis. 2:40–61. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schirrmacher V, Haas C, Bonifer R, Ahlert
T, Gerhards R and Ertel C: Human tumor cell modification by virus
infection: an efficient and safe way to produce cancer vaccine with
pleiotropic immune stimulatory properties when using Newcastle
disease virus. Gene Ther. 6:63–73. 1999. View Article : Google Scholar
|
|
13
|
Fábián Z, Csatary CM, Szeberényi J and
Csatary LK: p53-independent endoplasmic reticulum stress-mediated
cytotoxicity of a Newcastle disease virus strain in tumor cell
lines. J Virol. 81:2817–2830. 2007.PubMed/NCBI
|
|
14
|
Reichard KW, Lorence RM, Cascino CJ, et
al: Newcastle disease virus selectively kills human tumor cells. J
Surg Res. 52:448–453. 1992. View Article : Google Scholar
|
|
15
|
Schirrmacher V and Fournier P: Newcastle
disease virus: a promising vector therapy of cancer. Viral Therapy
of Cancer. Kevin JH, Richard GV and Hardev SP: Wiley; New Jersey:
pp. 171–186. 2008, View Article : Google Scholar
|
|
16
|
Elankumaran S, Rockemann D and Samal SK:
Newcastle disease virus exerts oncolysis by both intrinsic and
extrinsic caspase-dependent pathways of cell death. J Virol.
80:7522–7534. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Washburn B, Weigand MA, Grosse-Wilde A, et
al: TNF-related apoptosis-inducing ligand mediates tumoricidal
activity of human monocytes stimulated by Newcastle disease virus.
J Immunol. 170:1814–1821. 2003. View Article : Google Scholar
|
|
18
|
Lorence RM, Rood PA and Kelley KW:
Newcastle disease virus as an antineoplastic agent: induction of
tumor necrosis factor-α and augmentation of its cytotoxicity. J
Natl Cancer Inst. 80:1305–1312. 1988.
|
|
19
|
Pitti RM, Marsters SA, Ruppert S, Donahue
CJ, Moore A and Ashkenazi A: Induction of apoptosis by Apo-2
ligand, a new member of the tumor necrosis factor cytokine family.
J Biol Chem. 271:12687–12690. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Walczak H, Miller RE, Ariail K, et al:
Tumoricidal activity of tumor necrosis factor-related
apoptosis-inducing ligand in vivo. Nat Med. 5:157–163. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun Y, Jin N, Mi Z, Li X, Lian H and Li P:
Induction of apoptosis in human hepatoma cell line SMMC7721 by
Newcastle disease virus HN gene. Zhonghua Zhong Liu Za Zhi.
27:279–282. 2005.(In Chinese).
|
|
22
|
Zeng J, Fournier P and Schirrmacher V:
Induction of interferon-α and tumor necrosis factor-related
apoptosis-inducing ligand in human blood mononuclear cells by
hemagglutinin-neuraminidase but not F protein of Newcastle disease
virus. Virology. 297:19–30. 2002.
|
|
23
|
Schirrmacher V, Haas C, Bonifer R and
Ertel C: Virus potentiation of tumor vaccine T-cell stimulatory
capacity requires cell surface binding but not infection. Clin
Cancer Res. 3:1135–1148. 1997.PubMed/NCBI
|
|
24
|
Sui H, Bai Y, Wang K, et al: The
anti-tumor effect of Newcastle disease virus HN protein is
influenced by differential subcellular targeting. Cancer Immunol
Immunother. 59:989–999. 2010. View Article : Google Scholar
|
|
25
|
Ni J, Galani IE, Cerwenka A, Schirrmacher
V and Fournier P: Antitumor vaccination by Newcastle disease virus
hemagglutinin-neuraminidase plasmid DNA application: changes in
tumor microenvironment and activation of innate anti-tumor
immunity. Vaccine. 29:1185–1193. 2011. View Article : Google Scholar
|
|
26
|
Ravindra P, Tiwari AK, Sharma B, et al: HN
protein of Newcastle disease virus causes apoptosis in chicken
embryo fibroblast cells. Arch Virol. 153:749–754. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alabsi AM, Bakar SAA, Ali R, et al:
Effects of Newcastle disease virus strains AF2240 and V4-UPM on
cytolysis and apoptosis of leukemia cell lines. Int J Mol Sci.
12:8645–8660. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ali R, Alabsi AM, Ali AM, et al: Cytolytic
effects and apoptosis induction of Newcastle disease virus strain
AF2240 on anaplastic astrocytoma brain tumor cell line. Neurochem
Res. 36:2051–2062. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Molouki A and Yusoff K: NDV-induced
apoptosis in absence of Bax; evidence of involvement of apoptotic
proteins upstream of mitochondria. Virol J. 9:1792012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bakar SAA, Zawawi M, Ali AM and Ideris A:
Induction of apoptosis by Newcastle disease virus strains AF220 and
V4-UPM in human promyelocytic leukemia (HL60) and human
T-lymphoblastic leukemia (CEM-SS) cells. World Acad Sci Eng
Technol. 64:395–399. 2012.
|
|
31
|
Molouki A, Hsu YT, Jahanshiri F, Rosli R
and Yusoff K: Newcastle disease virus infection promotes Bax
redistribution to mitochondria and cell death in HeLa cells.
Intervirology. 53:87–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yusoff K, Tan WS, Lau CH, Ng BK and
Ibrahim AL: Sequence of the haemagglutinin-neuraminidase gene of
the Newcastle disease virus oral vaccine strain V4(UPM). Avian
Pathol. 25:837–844. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nicoletti I, Migliorati G, Pagliacci M,
Grignani F and Riccardi C: A rapid and simple method for measuring
thymocyte apoptosis by propidium iodide staining and flow
cytometry. J Immunol Methods. 139:271–279. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hale AJ, Smith CA, Sutherland LC, et al:
Apoptosis: molecular regulation of cell death. Eur J Biochem.
236:1–26. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Elmore S: Apoptosis: a review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
O’Brien V: Viruses and apoptosis. J Gen
Virol. 79:1833–1845. 1998.
|
|
37
|
Vaux DL: Toward an understanding of the
molecular mechanisms of physiological cell death. Proc Natl Acad
Sci USA. 90:786–789. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cohen JJ, Duke RC, Fadok VA and Sellins
KS: Apoptosis and programmed cell death in immunity. Annu Rev
Immunol. 10:267–293. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Csatary LK and Bakács T: Use of Newcastle
disease virus vaccine (MTH-68/H) in a patient with high-grade
glioblastoma. JAMA. 281:1588–1589. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Freeman AI, Zakay-Rones Z, Gomori JM, et
al: Phase I/II trial of intravenous NDV-HUJ oncolytic virus in
recurrent glioblastoma multiforme. Mol Ther. 13:221–228. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Karcher J, Dyckhoff G, Beckhove P, et al:
Antitumor vaccination in patients with head and neck squamous cell
carcinomas with autologous virus-modified tumor cells. Cancer Res.
64:8057–8061. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pecora AL, Rizvi N, Cohen GI, et al: Phase
I trial of intravenous administration of PV701, an oncolytic virus,
in patients with advanced solid cancers. J Clin Oncol.
20:2251–2266. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Schirrmacher V: Clinical trials of
antitumor vaccination with an autologous tumor cell vaccine
modified by virus infection: improvement of patient survival based
on improved antitumor immune memory. Cancer Immunol Immunother.
54:587–598. 2005. View Article : Google Scholar
|
|
44
|
Steiner HH, Bonsanto MM, Beckhove P, et
al: Antitumor vaccination of patients with glioblastoma multiforme:
a pilot study to assess feasibility, safety, and clinical benefit.
J Clin Oncol. 22:4272–4281. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou J, Law HKW, Cheung CY, Ng IHY, Peiris
JSM and Lau YL: Functional tumor necrosis factor-related
apoptosis-inducing ligand production by avian influenza
virus-infected macrophages. J Infect Dis. 193:945–953. 2006.
View Article : Google Scholar
|
|
46
|
Clarke P, Meintzer SM, Gibson S, et al:
Reovirus-induced apoptosis is mediated by TRAIL. J Virol.
74:8135–8139. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vidalain PO, Azocar O, Lamouille B, Astier
A, Rabourdin-Combe C and Servet-Delprat C: Measles virus induces
functional TRAIL production by human dendritic cells. J Virol.
74:556–559. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kotelkin A, Prikhod’ko EA, Cohen JI,
Collins PL and Bukreyev A: Respiratory syncytial virus infection
sensitizes cells to apoptosis mediated by tumor necrosis
factor-related apoptosis-inducing ligand. J Virol. 77:9156–9172.
2003. View Article : Google Scholar
|
|
49
|
Collins PL and Hightower LE: Newcastle
disease virus stimulates the cellular accumulation of stress (heat
shock) mRNAs and proteins. J Virol. 44:703–707. 1982.PubMed/NCBI
|
|
50
|
Sunila I, Vaccarezza M, Pantaleo G, Fauci
AS and Orenstein JM: gp120 is present on the plasma membrane of
apoptotic CD4 cells prepared from lymph nodes of HIV-1-infected
individuals: an immunoelectron microscopic study. AIDS. 11:27–32.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Connolly JL, Barton ES and Dermody TS:
Reovirus binding to cell surface sialic acid potentiates
virus-induced apoptosis. J Virol. 75:4029–4039. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fournier P, Zeng J and Schirrmacher V: Two
ways to induce innate immune responses in human PBMCs: Paracrine
stimulation of IFN-α responses by viral protein or dsRNA. Int J
Oncol. 23:673–680. 2003.PubMed/NCBI
|
|
53
|
Washburn B and Schirrmacher V: Human tumor
cell infection by Newcastle disease virus leads to upregulation of
HLA and cell adhesion molecules and to induction of interferons,
chemokines and finally apoptosis. Int J Oncol. 21:85–93.
2002.PubMed/NCBI
|
|
54
|
Szeberényi J, Fábián Z, Töröcsik B, Kiss K
and Csatary LK: Newcastle disease virus-induced apoptosis in PC12
pheochromocytoma cells. Am J Ther. 10:282–288. 2003.PubMed/NCBI
|
|
55
|
Molouki A, Hsu YT, Jahanshiri F, Abdullah
S, Rosli R and Yusoff K: The matrix (M) protein of Newcastle
disease virus binds to human bax through its BH3 domain. Virol J.
8:3852011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Préhaud C, Lay S, Dietzschold B and Lafon
M: Glycoprotein of nonpathogenic rabies viruses is a key
determinant of human cell apoptosis. J Virol. 77:10537–10547.
2003.PubMed/NCBI
|
|
57
|
Tan W, Lau C, Ng B, Ibrahim A and Yusoff
K: Nucleotide sequence of the haemagglutinin-neuraminidase (HN)
gene of a Malaysian heat resistant viscerotropic-velogenic
Newcastle disease virus (NDV) strain AF2240. DNA Seq. 6:47–50.
1995.
|
|
58
|
Mymryk J, Shire K and Bayley S: Induction
of apoptosis by adenovirus type 5 E1A in rat cells requires a
proliferation block. Oncogene. 9:1187–1193. 1994.PubMed/NCBI
|
|
59
|
Joe AK, Foo HH, Kleeman L and Levine B:
The transmembrane domains of Sindbis virus envelope glycoproteins
induce cell death. J Virol. 72:3935–3943. 1998.PubMed/NCBI
|
|
60
|
Yao Q, Compans RW and Chen C: HIV envelope
proteins differentially utilize CXCR4 and CCR5 coreceptors for
induction of apoptosis. Virology. 285:128–137. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang K, Sui H, Li L, Li X and Wang L:
Anti-tumor immunity of Newcastle disease virus HN protein is
influenced by differential subcellular targeting. Zhongguo Fei Ai
Za Zhi. 13:773–776. 2010.(In Chinese).
|
|
62
|
Castedo M, Roumier T, Blanco J, et al:
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced
by the HIV-1 envelope. EMBO J. 21:4070–4080. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lam KM, Kabbur MB and Eiserich JP:
Newcastle disease virus-induced functional impairments and
biochemical changes in chicken heterophils. Vet Immunol
Immunopathol. 53:313–327. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kommers GD, King DJ, Seal BS and Brown CC:
Pathogenesis of chicken-passaged Newcastle disease viruses isolated
from chickens and wild and exotic birds. Avian Dis. 47:319–329.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ravindra P, Tiwari AK, Ratta B, Chaturvedi
U, Palia SK and Chauhan R: Newcastle disease virus-induced
cytopathic effect in infected cells is caused by apoptosis. Virus
Res. 141:13–20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Vigil A, Park MS, Martinez O, et al: Use
of reverse genetics to enhance the oncolytic properties of
Newcastle disease virus. Cancer Res. 67:8285–8292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Bian H, Fournier P, Moormann R, Peeters B
and Schirrmacher V: Selective gene transfer to tumor cells by
recombinant Newcastle disease virus via a bispecific fusion
protein. Int J Oncol. 26:431–439. 2005.PubMed/NCBI
|
|
68
|
Ertel C, Millar NS, Emmerson PT,
Schirrmacher V and Von Hoegen P: Viral hemagglutinin augments
peptide-specific cytotoxic T cell responses. Eur J Immunol.
23:2592–2596. 1993. View Article : Google Scholar : PubMed/NCBI
|
